[Annual progress of interventional pulmonology in 2025].
1/5 보강
In 2025, interventional pulmonology continues to progress rapidly through technological innovation and multidisciplinary integration, playing an increasingly prominent role in the diagnosis and manage
APA
Xu XY, Chen HJ, Li SY (2026). [Annual progress of interventional pulmonology in 2025].. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 49(3), 351-355. https://doi.org/10.3760/cma.j.cn112147-20260104-00004
MLA
Xu XY, et al.. "[Annual progress of interventional pulmonology in 2025].." Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, vol. 49, no. 3, 2026, pp. 351-355.
PMID
41820044
Abstract
In 2025, interventional pulmonology continues to progress rapidly through technological innovation and multidisciplinary integration, playing an increasingly prominent role in the diagnosis and management of respiratory diseases. Significant developments are primarily reflected in the maturation of navigational and robotic bronchoscopy technologies, the emergence of transbronchial interventional ablation as a key therapeutic modality for peripheral lung cancer, the expanding repertoire of interventional techniques offering more treatment options for patients with airway diseases, and the transformative potential introduced by artificial intelligence and regenerative medicine. Together, these advances are steering interventional pulmonology toward greater efficiency, precision, intelligence, and personalization.
MeSH Terms
Humans; Bronchoscopy; Pulmonary Medicine; Lung Neoplasms; Artificial Intelligence; Robotics
같은 제1저자의 인용 많은 논문 (2)
- Reliable diagnosis of liver focal nodular hyperplasia by a combination of T2 weighted signal and three diffusion magnetic resonance metrics of diffusion-derived 'vessel density', slow diffusion coefficient, and apparent diffusion coefficient: a validation study of two centers' data.
- Intelligent plant exosomes synergize miRNAs and cisplatin for spatiotemporally precise multimodal treatment for TNBC with high safety.